Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Svensson

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Antimicrobial Agents and Chemotherapy|July 31, 2019
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid CultureRobin J Svensson, Wilber Sabiiti, Gibson S Kibiki, et al.
Scientific Reports|April 11, 2018
Improving treatment outcome assessment in a mouse tuberculosis modelBas C Mourik, Robin J Svensson, Gerjo J de Knegt, et al.
The Journal of Infectious Diseases|May 3, 2018
Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial SimulationsRobin J Svensson, Elin M Svensson, Rob E Aarnoutse, et al.
Frontiers in Pharmacology|March 31, 2023
Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug developmentRami Ayoun Alsoud, Robin J Svensson, Elin M Svensson, et al.
Journal of Clinical Pharmacology|December 29, 2021
Population Pharmacokinetics and Exposure-Response Relationships of Astegolimab in Patients With Severe AsthmaNaoki Kotani, Michael Dolton, Robin J Svensson, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 4, 2021
Population repeated time-to-event analysis of exacerbations in asthma patients: A novel approach for predicting asthma exacerbations based on biomarkers, spirometry, and diaries/questionnairesRobin J Svensson, Jakob Ribbing, Naoki Kotani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2018
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary TuberculosisElin M Svensson, Robin J Svensson, Lindsey H M Te Brake, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Antimicrobial Agents and Chemotherapy|July 31, 2019
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid CultureRobin J Svensson, Wilber Sabiiti, Gibson S Kibiki, et al.
Scientific Reports|April 11, 2018
Improving treatment outcome assessment in a mouse tuberculosis modelBas C Mourik, Robin J Svensson, Gerjo J de Knegt, et al.
The Journal of Infectious Diseases|May 3, 2018
Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial SimulationsRobin J Svensson, Elin M Svensson, Rob E Aarnoutse, et al.
Frontiers in Pharmacology|March 31, 2023
Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug developmentRami Ayoun Alsoud, Robin J Svensson, Elin M Svensson, et al.
Journal of Clinical Pharmacology|December 29, 2021
Population Pharmacokinetics and Exposure-Response Relationships of Astegolimab in Patients With Severe AsthmaNaoki Kotani, Michael Dolton, Robin J Svensson, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 4, 2021
Population repeated time-to-event analysis of exacerbations in asthma patients: A novel approach for predicting asthma exacerbations based on biomarkers, spirometry, and diaries/questionnairesRobin J Svensson, Jakob Ribbing, Naoki Kotani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2018
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary TuberculosisElin M Svensson, Robin J Svensson, Lindsey H M Te Brake, et al.
Pageof 2